Quarterly Activities & Cashflow Report
Filed with ASX · · 10 pages · English
Summary by 6ix AI
HeraMED Ltd has released its Quarterly Activities and Cashflow Report for the September quarter, detailing significant advancements in its US commercialisation strategy, particularly with Lee Health's full deployment of the Digital Pregnancy Journey. The report highlights a successful transition from pilot to commercial deployment, securing an initial contract and integrating with Epic EMR to enhance scalability across US health systems. Financially, the company reported a strengthened cash position, with a notable increase following the receipt of a significant payment from Lee Health, which supports ongoing operational activities. Overall, the report emphasizes HeraMED's focus on executing its commercial strategy and expanding its partnerships to drive growth in the US market.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from HeraMED
- Lee Health Approves Expansion of HeraMED Maternity Program
- Trading Halt
- Notification regarding unquoted securities - HMD
- Appendix 4D and Half Year Report
- Resignation and Appointment of Joint Company Secretary
Later from HeraMED
All HeraMED news releasesFollow HeraMED into a list and get an email when it puts out news.
Follow HeraMED